The deal would give the French company a pharmaceutical monopoly over Pompe Disease therapy. The Federal Trade Commission (FTC) has taken action to prevent Sanofi from acquiring an…
Read MorePharmaceuticals
Senator Sanders Plans to Work with New NIH Director
The senator believes fair pricing can be built into federal contracts with pharmaceutical companies. Senator Bernie Sanders of Vermont plans to work with the new director of the…
Read More
FDA Approves New Treatment for Rare Blood Clotting Disorder
Director Marks announced the therapy for the life-threatening disorder. The U.S. Food and Drug Administration recently approved Adzynma for patients with congenital thrombotic thrombocytopenic purpura (cTTP). The genetically…
Read More
FDA Launches Pilot Program to Develop Rare Disease Therapies
A limited number of sponsors will be allowed to participate. The U.S. Food and Drug Administration (FDA) has launched the Support for clinical Trials Advancing Rare disease Therapeutics…
Read More
Healthcare Workers Union Coalition Strike Begins
Union negotiators say compensation proposals do not reflect the cost of living. A strike of more than 75,000 healthcare workers with the Coalition of Kaiser Permanente Unions began…
Read More
HHS Recommends Easing Marijuana Restrictions
Recommendation prompts the DEA to conduct a final review for reschedulization. The Department of Health and Human Services (HHS) has announced that the department recommends the reclassification of…
Read More
White House Advisor Certain of Legality of Drug Price Negotiations
Pharmaceutical companies challenge the administration in court over negotiations by Medicare. White House Domestic Policy Council Director Neera Tanden expressed confidence in the legality of Medicare’s new program…
Read MoreAdministration Announces Prescriptions Available for Price Negotiations
Ten drugs will be negotiated, with new pricing as of 2026. President Biden’s administration has announced the first 10 prescription drugs available for Medicare price negotiations. The pharmaceuticals…
Read More
Appeals Court Rules to Limit Access to Abortion Drug
Mifepristone was not ordered to be removed from the market, and the case goes to Supreme Court. The 5th Circuit Court of Appeals ruled that the Food and…
Read More
FDA and DEA Address Stimulant Medicine Shortage
Agency heads request an increase from manufacturers and for healthcare providers to slow demand. The Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) are taking steps…
Read More